These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11765298)

  • 1. Adherence to oral montelukast and inhaled fluticasone in children with persistent asthma.
    Sherman J; Patel P; Hutson A; Chesrown S; Hendeles L
    Pharmacotherapy; 2001 Dec; 21(12):1464-7. PubMed ID: 11765298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial.
    Rand C; Bilderback A; Schiller K; Edelman JM; Hustad CM; Zeiger RS;
    J Allergy Clin Immunol; 2007 Apr; 119(4):916-23. PubMed ID: 17349681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study.
    Garcia Garcia ML; Wahn U; Gilles L; Swern A; Tozzi CA; Polos P
    Pediatrics; 2005 Aug; 116(2):360-9. PubMed ID: 16061590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
    O'Connor RD; Nelson H; Borker R; Emmett A; Jhingran P; Rickard K; Dorinsky P
    Pharmacoeconomics; 2004; 22(12):815-25. PubMed ID: 15294013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to asthma controller medication regimens.
    Stempel DA; Stoloff SW; Carranza Rosenzweig JR; Stanford RH; Ryskina KL; Legorreta AP
    Respir Med; 2005 Oct; 99(10):1263-7. PubMed ID: 16140227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of low-dose fluticasone propionate compared with montelukast for maintenance treatment of persistent asthma.
    Meltzer EO; Lockey RF; Friedman BF; Kalberg C; Goode-Sellers S; Srebro S; Edwards L; Rickard K;
    Mayo Clin Proc; 2002 May; 77(5):437-45. PubMed ID: 12004993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic impact of asthma therapy with fluticasone propionate, montelukast, or zafirlukast in a managed care population.
    Pathak DS; Davis EA; Stanford RH
    Pharmacotherapy; 2002 Feb; 22(2):166-74. PubMed ID: 11837555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized comparison of strategies for reducing treatment in mild persistent asthma.
    ; Peters SP; Anthonisen N; Castro M; Holbrook JT; Irvin CG; Smith LJ; Wise RA
    N Engl J Med; 2007 May; 356(20):2027-39. PubMed ID: 17507702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.
    O'Connor RD; Stanford R; Crim C; Yancey SW; Edwards L; Rickard KA; Dorinsky P
    Ann Allergy Asthma Immunol; 2004 Dec; 93(6):581-8. PubMed ID: 15609769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes associated with initiation of different controller therapies in a Medicaid asthmatic population: a retrospective data analysis.
    Balkrishnan R; Nelsen LM; Kulkarni AS; Pleasants RA; Whitmire JT; Schechter MS
    J Asthma; 2005 Feb; 42(1):35-40. PubMed ID: 15801326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of asthma-related expenditures for patients started on montelukast versus fluticasone propionate as monotherapy.
    Bukstein DA; Henk HJ; Luskin AT
    Clin Ther; 2001 Sep; 23(9):1589-600. PubMed ID: 11589270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Real-world" effectiveness of daily controller medicine in children with mild persistent asthma.
    Bukstein DA; Luskin AT; Bernstein A
    Ann Allergy Asthma Immunol; 2003 May; 90(5):543-9. PubMed ID: 12775136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies.
    Stoloff SW; Stempel DA; Meyer J; Stanford RH; Carranza Rosenzweig JR
    J Allergy Clin Immunol; 2004 Feb; 113(2):245-51. PubMed ID: 14767437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of asthma-related health care resource use in children treated with montelukast or fluticasone.
    Allen-Ramey FC; Markson LE; Riedel AA; Sajjan S; Weiss KB
    Curr Med Res Opin; 2006 Aug; 22(8):1453-61. PubMed ID: 16870071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical effectiveness of inhaled corticosteroids versus montelukast in children with asthma: prescription patterns and patient adherence as key factors.
    Ducharme FM; Noya FJ; Allen-Ramey FC; Maiese EM; Gingras J; Blais L
    Curr Med Res Opin; 2012 Jan; 28(1):111-9. PubMed ID: 22077107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial.
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening AP; Haahtela T; Holgate ST; Picado C; Menten J; Dass SB; Leff JA; Polos PG
    BMJ; 2003 Oct; 327(7420):891. PubMed ID: 14563743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial.
    Zeiger RS; Bird SR; Kaplan MS; Schatz M; Pearlman DS; Orav EJ; Hustad CM; Edelman JM
    Am J Med; 2005 Jun; 118(6):649-57. PubMed ID: 15922697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled corticosteroids or montelukast as the preferred primary long-term treatment for pediatric asthma?
    Jartti T
    Eur J Pediatr; 2008 Jul; 167(7):731-6. PubMed ID: 18214538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to combined montelukast and fluticasone treatment in economically disadvantaged african american youth with asthma.
    McNally KA; Rohan J; Schluchter M; Riekert KA; Vavrek P; Schmidt A; Redline S; Kercsmar C; Drotar D
    J Asthma; 2009 Nov; 46(9):921-7. PubMed ID: 19905919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast.
    Jayaram L; Pizzichini E; Lemière C; Man SF; Cartier A; Hargreave FE; Pizzichini MM
    Thorax; 2005 Feb; 60(2):100-5. PubMed ID: 15681495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.